A paper co-authored by Emily Day, “miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma”, has been selected as the cover of an upcoming issue of Genes & Development. The paper identifies a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM), a deadly and incurable type of brain tumor. The researchers used nanoparticles called spherical nucleic acids to safely deliver miR-182 across the blood-brain/blood-tumor barriers to reach tumor cells where they directly suppressed multiple oncogenes at once, increasing cancer cell death, reducing tumor growth, and improving overall survival. This approach offers a novel strategy for therapeutic intervention in GBM.
- Halting a heart attack’s hidden harmUD’s Elise Corbin develops novel tools to advance cardiac research.
- Making a differenceUD undergraduate builds organ-on-a-chip models to help study female reproductive tract.
- Spring News from BMEI am pleased to announce that our new Masters in Quantitative Systems Pharmacology (QSP) program is accepting applications for Fall 2025! This program builds on UD’s strong record of placing our students in industry leadership positions in QSP.
- Clinical Insight: Jenna Averill’s Winter Immersion with Rothman OrthopaedicsStudents identify real-world challenges in clinical settings.
- UD top-ranked graduate degree programsU.S. News & World Report names University of Delaware graduate degree programs among the best in the nation